Safran, Howard
Brown University · Lifespan
4 papers on CoChatORCID 0000-0002-6221-7147
Most cited papers
- Verified
Avelumab, an Anti–Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study
Apolo, A. B., Infante, J. R., Balmanoukian, A., Patel, M. R., Wang, D., Kelly, K., Mega, A. E., Britten, C. D., Ravaud, A., Mita, A. C., et al. (2017) · Journal of Clinical Oncology
Cancer Immunotherapy and BiomarkersBladder and Urothelial Cancer Treatments
Cited by 585
- Verified
Phase II Trial of Cetuximab, Gemcitabine, and Oxaliplatin Followed by Chemoradiation With Cetuximab for Locally Advanced (T4) Pancreatic Adenocarcinoma: Correlation of Smad4(Dpc4) Immunostaining With Pattern of Disease Progression
Crane, C. H., Varadhachary, G. R., Yordy, J. S., Staerkel, G. A., Javle, M. M., Safran, H., Haque, W., Hobbs, B. D., Krishnan, S., Fleming, J. B., et al. (2011) · Journal of Clinical Oncology
Pancreatic and Hepatic Oncology ResearchPancreatitis Pathology and Treatment
Cited by 288
- Verified
AMG-232 sensitizes high MDM2-expressing tumor cells to T-cell-mediated killing
Sahin, I., Zhang, S., Navaraj, A., Zhou, L., Dizon, D., Safran, H., & El-Deiry, W. S. (2020) · Cell Death Discovery
Cancer-related Molecular PathwaysCancer Immunotherapy and Biomarkers
Cited by 66
- Verified
The Landscape of Glycogen Synthase Kinase-3 Beta Genomic Alterations in Cancer
Borden, B. A., Baca, Y., Xiu, J., Tavora, F., Winer, I., Weinberg, B. A., Vanderwalde, A. M., Darabi, S., Korn, W. M., Mazar, A. P., et al. (2021) · Molecular Cancer Therapeutics
Cancer Genomics and DiagnosticsCancer Immunotherapy and Biomarkers
Cited by 15
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free